Advertisement

Bumetanide Injection

[16 October 2014]

Products Affected - Description

Bumetanide 0.25 mg/mL, Ben Venue (formerly Bedford products)
2 mL vial (NDC 55390-0500-02)
4 mL vial (NDC 55390-0500-05)
10 mL vial (NDC 55390-0500-10) 

Reason for the Shortage

  • Ben Venue closed its plant in Bedford, Ohio in July 2014.
  • Baxter discontinued bumetanide 0.25 mg/mL 2 mL vial in early-2011.
  • West-Ward acquired several Baxter products including bumetanide in mid-2011. Bumetanide was on shortage because demand exceeded supply.
  • Hospira had bumetanide on shortage due to manufacturing delays.

Available Products

Bumetanide 0.25 mg/mL, Hospira
4 mL vial (NDC 00409-1412-04)
10 mL vial (NDC 00409-1412-10)

 
Bumetanide 0.25 mg/mL, West-Ward
4 mL vial (NDC 00641-6008-10)
10 mL vial (NDC 00641-6007-10)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

Updated

October 16, 2014; August 18, 2014; June 24, 2014; May 27, 2014; May 13, 2014; May 8, 2014; April 30, 2014; March 21, 2014; March 5, 2014; February 21, 2014; February 10, 2014; February 7, 2014; January 21, 2014; December 18, 2013; September 30, 2013; August 22, 2013; July 25, 2013; July 11, 2013; June 6, 2013; May 20, 2013; May 6, 2013; April 24, 2013; March 29, 2013; March 7, 2013; February 15, 2013; January 28, 2013; January 23, 2013; January 15, 2013; December 19, 2012; November 27, 2012; November 1, 2012; October 15, 2012; October 3, 2012; September 17, 2012; September 5, 2012; August 7, 2012; July 12, 2012; July 10, 2012; May 24, 2012; April 18, 2012; April 4, 2012; March 21, 2012; March 12, 2012; February 21, 2012; February 3, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement